| ICD-10 Codes Classified as "Level 2" - Drug Type: Non-intoxicant |
| ICD-10 Code |
Description |
Tally |
| T36.0 | Penicillins | 1 |
| T36.5 | Aminoglycosides | 6 |
| T36.7 | Antifungal Antibiotics, Systemically Used | 2 |
| T36.8 | Other Systemic Antibiotics | 5 |
| T37.1 | Antimycobacterial Drugs | 5 |
| T37.2 | Antimalarials | 7 |
| T37.5 | Antiviral Drugs | 1 |
| T37.8 | Other Specified Systemic Anti-infectives and Antiparasitics | 8 |
| T38.1 | Thyroid Hormones and Substitutes | 2 |
| T38.3 | Insulin and Oral Hypoglycaemic [Antidiabetic] Drugs | 98 |
| T38.5 | Other Estrogens and Progestogens | 1 |
| T38.7 | Androgens and Anabolic Congeners | 1 |
| T38.8 | Other and Unspecified Hormone Antagonists | 2 |
| T39.0 | Salicylates | 182 |
| T39.1 | 4-Aminol Derivatives | 643 |
| T39.2 | Pyrazolone Derivatives | 1 |
| T39.3 | Other Nonsteroidal Anti-inflammatory Drugs [NSAID] | 219 |
| T39.8 | Other Nonopioid Analgesics and Antipyretics, not Elsewhere Classified | 31 |
| T42.0 | Hydantoin Derivatives | 36 |
| T42.1 | Iminostilbenes | 51 |
| T42.2 | Succinimides and Oxazolidinediones | 2 |
| T42.5 | Mixed Antiepileptics, Not Elsewhere Classified | 1 |
| T42.8 | Antiparkinsonism Drugs and Other Central Muscle-tone Depressants | 353 |
| T43.0 | Tricyclic and Tetracyclic Antidepressants | 1,259 |
| T43.1 | Monoamine-Oxidase-Inhibitor Antidepressants | 6 |
| T43.2 | Other and Unspecified Antidepressants | 1,499 |
| T43.3 | Phenothiazine Antipsychotics and Neuroleptics | 198 |
| T43.4 | Butyrophenone and Thioxanthene Neuroleptics | 11 |
| T43.5 | Other and Unspecified Antipsychotics and Neuroleptics | 518 |
| T44.0 | Anticholinesterase Agents | 2 |
| T44.1 | Other Parasympathomimetics [Cholinergics] | 1 |
| T44.3 | Other Parasympatholytics [Anticholinergics and Antimuscarinics] and Spasmolytics, not Elsewhere Classified | 16 |
| T44.5 | Predominantly Beta-adrenoreceptor Agonists, not Elsewhere Classified | 1 |
| T44.7 | Beta-adrenoreceptor Antagonists, not Elsewhere Classified | 45 |
| T44.8 | Centrally Acting and Adrenergic-neuron-blocking Agents, not Elsewhere Classified | 1 |
| T44.9 | Other and Unspecified Drugs Primarily Affecting the Autonomic Nervous System | 97 |
| T45.0 | Antiallergic and Antiemetic Drugs | 853 |
| T45.1 | Antineoplastic and Immunosuppressive Drugs | 63 |
| T45.3 | Enzymes, not Elsewhere Classified | 1 |
| T45.4 | Iron and its Compounds | 1 |
| T45.5 | Anticoagulants | 107 |
| T45.7 | Anticoagulant Antagonists, Vitamin K and Other Coagulants | 1 |
| T45.8 | Other Primarily Systemic and Haematological Agents | 3 |
| T46.0 | Cardiac-stimulant Glycosides and Drugs of Similar Action | 104 |
| T46.1 | Calcium-channel Blockers | 115 |
| T46.2 | Other Antidysrhythmic Drugs, not Elsewhere Classified | 89 |
| T46.3 | Coronary Vasodilators, not Elsewhere Classified | 3 |
| T46.4 | Angiotensin-converting-enzyme Inhibitors | 5 |
| T46.5 | Other Antihypertensive Drugs, not Elsewhere Classified | 8 |
| T46.9 | Other and Unspecified Agents Primarily Affecting the Cardiovascular System | 2 |
| T47.0 | Histamine H2-receptor Antagonists | 1 |
| T47.5 | Digestants | 2 |
| T47.6 | Antidiarrhoeal Drugs | 3 |
| T47.7 | Emetics | 1 |
| T48.1 | Skeletal Muscle Relaxants [Neuromuscular Blocking Agents] | 37 |
| T48.2 | Other and Unspecified Agents Primarily Acting on Muscles | 1 |
| T48.6 | Antiasthmatics, not Elsewhere Classified | 18 |
| T48.7 | Other and Unspecified Agents Primarily Acting on the Respiratory System | 52 |
| T49.0 | Local Antifungal, Anti-infective and Anti-inflammatory drugs, not Elsewhere Classified | 8 |
| T49.2 | Local Astringents and Local Detergents | 3 |
| T49.3 | Emollients, Demulcents and Protectants | 1 |
| T49.4 | Keratolytics, Keratoplastics and Other Hair Treatment Drugs and Preparations | 9 |
| T49.5 | Ophthalmological Drugs and Preparations | 1 |
| T49.6 | Otorhinolaryngological Drugs and Preparations | 2 |
| T49.7 | Dental Drugs, Topically Applied | 1 |
| T49.8 | Other Topical Agents | 1 |
| T49.9 | Topical Agent, Unspecified | 3 |
| T50.2 | Carbonic-anhydrase Inhibitors, Benzothiadiazides and Other Diuretics | 4 |
| T50.3 | Electrolytic, Caloric and Water-balance Agents | 3 |
| T50.4 | Drugs Affecting Uric Acid Metabolism | 6 |
| T50.6 | Antidotes and Chelating Agents, not Elsewhere Classified | 1 |
| T50.7 | Analeptics and Opioid Receptor Antagonists | 1 |
| T50.8 | Diagnostic Agents | 8 |
| X40 | Nonopioid Analgesics, Antipyretics and Antirheumatics | 227 |
| X43 | Other Drugs Acting on the Autonomic Nervous System | 219 |
| X47 | Other Gases and Vapours | 25 |
| X60 | Nonopioid Analgesics, Antipyretics and Antirheumatics | 242 |
| X63 | Other Drugs Acting on the Autonomic Nervous System | 11 |
| Y10 | Nonopioid Analgesics, Antipyretics and Antirheumatics | 2 |
| Y13 | Other Drugs Acting on the Autonomic Nervous System | 100 |
| Y40.1 | Cefalosporins and Other Beta-lactam Antibiotics | 1 |
| Y40.2 | Chloramphenicol Group | 2 |
| Y42.3 | Insulin and Oral Hypoglycaemic [Antidiabetic] Drugs | 1 |
| Y42.7 | Androgens and Anabolic Congeners | 5 |
| Y44.2 | Anticoagulants | 3 |
| Y44.5 | Thrombolytic Drugs | 1 |
| Y45.8 | Other Analgesics and Antipyretics | 1 |
| Y48.3 | Local Anaesthetics | 4 |
| Y49.3 | Phenothiazine Antipsychotics and Neuroleptics | 1 |
| Y52.0 | Cardiac-stimulant Glycosides and Drugs of Similar Action | 1 |
| Y52.3 | Coronary Vasodilators, not Elsewhere Classified | 1 |
| Y52.4 | Angiotensin-converting-enzyme Inhibitors | 1 |
| Y57.5 | X-ray Contrast Media | 1 |